When will Gleevec (STI571) be approved for prescription sale in the U.S.A. and other Countries?
Gleevec was approved by the United States Food and Drug Administration (FDA) for prescription sale in the United States on May 10, 2001. Other countries have different approval processes. To date, Gleevec (Glivec) has been approved for prescription use in the following countries: Argentina, Australia, Bulgaria, Canada, Chile, Columbia, Dominican Republic, Ecuador, El Salvador, Guatemala, Israel, Indonesia, Japan, Jordan, Kuwait, Malta, Mexico, Nicaragua, Palestine, Peru, Romania, Russia, South Korea, Switzerland, Syria, United States, Uruguay, Venezuela.
Related Questions
- How does the law read concerning importation of prescription medications from other countries that are not approved for use in the United States?
- I live outside of the U.S.A. What other Countries are participating in the Gleevec (STI571) trials?
- When will Gleevec (STI571) be approved for prescription sale in the U.S.A. and other Countries?
